Skip to main content
Clinical Trials/ITMCTR2100004922
ITMCTR2100004922RecruitingPhase 1

Clinical study on the collaborative treatment of Chinese and Western medicine for compliance HIV infected patients

Sichuan Provincial Administration of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 65 (—)
Sex
All

Inclusion Criteria

  • 1.They met the diagnostic criteria for HIV infection;
  • 2.After antiviral treatment for at least 48 weeks, HIV RNA > 1000 copies / ml;
  • 3.The compliance of antiviral drugs was less than 80%;
  • 4.Aged 18 to 65 years, regardless of gender;
  • 5.The subjects voluntarily participated and informed consent.

Exclusion Criteria

  • 1.Pregnant or lactating women; Or pregnant women;
  • 2.There were severe organic heart disease and arrhythmia; Abnormal liver and kidney function; Patients with active pulmonary tuberculosis or undergoing antituberculosis treatment; Patients with hematological diseases; Suffering from serious mental and neurological diseases;
  • 3.Patients with tumor;
  • 4.Allergic constitution and allergic to test drugs;
  • 5.Patients with history of alcohol abuse or alcohol dependence syndrome.

Investigators

Sponsor
Sichuan Provincial Administration of Traditional Chinese Medicine

Similar Trials

Clinical study on the collaborative... | Clinical Trial